Loading...
Docoh

Quotient (QTNT)

Building on over 30 years of experience in transfusion diagnostics, Quotient is a commercial-stage diagnostics company committed to delivering solutions that reshape the way diagnostics is practiced. MosaiQ, Quotient's proprietary multiplex microarray technology, offers the world's first fully automated, consolidated testing platform, allowing for multiple tests across different modalities. MosaiQ is designed to be a game-changing solution, which Quotient believes will increase efficiencies, improve clinical practice, deliver significant workflow improvements, and operational cost savings to laboratories around the world. In response to the global effort to combat COVID-19, Quotient developed the MosaiQ COVID-19 Antibody Microarray which is CE marked and has received the U.S. FDA Emergency Use Authorization. Quotient's operations are based in Eysins, Switzerland, Edinburgh, Scotland and Newtown, Pennsylvania.

Company profile

Ticker
QTNT
Exchange
CEO
Franz Walt
Employees
Incorporated
Location
Fiscal year end
SEC CIK
Subsidiaries
Alba Bioscience Limited • QBD (QS IP) Limited • Quotient Biodiagnostics, Inc. • Quotient Biocampus Limited • Quotient Iberia, S.L. • Quotient Suisse SA ...

QTNT stock data

Analyst ratings and price targets

Last 3 months
Current price
Average target
$2.25
Low target
$1.50
High target
$3.00
Cowen & Co.
Maintains
Outperform
$3.00
29 Jun 22
BTIG
Maintains
Buy
$1.50
29 Jun 22

Investment data

Data from SEC filings
Securities sold
Number of investors

Calendar

8 Aug 22
15 Aug 22
31 Mar 23
Quarter (USD) Jun 22 Mar 22 Dec 21 Sep 21
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS
Annual (USD) Mar 22 Mar 21 Mar 20 Mar 19
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS
Cash burn rate (est.) Burn method: Change in cash Burn method: Operating income Burn method: FCF (opex + capex)
Last Q Avg 4Q Last Q Avg 4Q Last Q Avg 4Q
Cash on hand (at last report) 54.88M 54.88M 54.88M 54.88M 54.88M 54.88M
Cash burn (monthly) 6.31M 5.66M 12.91M 11.43M 11.84M 10.21M
Cash used (since last report) 9.63M 8.65M 19.71M 17.45M 18.08M 15.59M
Cash remaining 45.24M 46.23M 35.16M 37.42M 36.8M 39.29M
Runway (months of cash) 7.2 8.2 2.7 3.3 3.1 3.8

Beta Read what these cash burn values mean

Date Owner Security Transaction Code Indirect 10b5-1 $Price #Shares $Value #Remaining
31 Jul 22 Catherine Larue Ordinary Shares Option exercise Acquire M No No 0 6,917 0 40,294
31 Jul 22 Catherine Larue RSU Ordinary Shares Option exercise Dispose M No No 0 6,917 0 6,917
31 Jul 22 Shroff Zubeen Ordinary Shares Option exercise Acquire M No No 0 13,538 0 131,999
31 Jul 22 Shroff Zubeen RSU Ordinary Shares Option exercise Dispose M No No 0 2,668 0 2,668
31 Jul 22 Shroff Zubeen RSU Ordinary Shares Option exercise Dispose M No No 0 10,870 0 10,868
31 Jul 22 Hallsworth Frederick Ordinary Shares Option exercise Acquire M No No 0 6,917 0 223,005
31 Jul 22 Hallsworth Frederick RSU Ordinary Shares Option exercise Dispose M No No 0 6,917 0 6,917
31 Jul 22 Wilkerson L John Ordinary Shares Option exercise Acquire M No No 0 11,660 0 106,618
31 Jul 22 Wilkerson L John RSU Ordinary Shares Option exercise Dispose M No No 0 790 0 792
31 Jul 22 Wilkerson L John RSU Ordinary Shares Option exercise Dispose M No No 0 10,870 0 10,868
56.0% owned by funds/institutions
13F holders Current Prev Q Change
Total holders 78 84 -7.1%
Opened positions 6 10 -40.0%
Closed positions 12 25 -52.0%
Increased positions 17 33 -48.5%
Reduced positions 35 30 +16.7%
13F shares Current Prev Q Change
Total value 91.24M 252.34M -63.8%
Total shares 76.04M 79.53M -4.4%
Total puts 11.4K 465.4K -97.6%
Total calls 150.8K 480.1K -68.6%
Total put/call ratio 0.1 1.0 -92.2%
Largest owners Shares Value Change
Perceptive Advisors 16.2M $19.44M 0.0%
Pura Vida Investments 10.16M $12.19M +17.4%
Polar Capital 9.25M $11.1M 0.0%
Highbridge Capital Management 9.12M $10.94M +24.2%
BLK Blackrock 5.38M $6.46M -0.9%
MS Morgan Stanley 4.83M $5.8M +29.8%
Clearbridge Advisors 4.26M $5.11M +0.8%
AMP Ameriprise Financial 3.67M $4.41M -28.7%
TimesSquare Capital Management 2.72M $3.26M -1.6%
Vanguard 1.77M $2.12M -2.4%
Largest transactions Shares Bought/sold Change
CS Credit Suisse 0 -2.39M EXIT
Highbridge Capital Management 9.12M +1.78M +24.2%
Artisan Partners Limited Partnership 438.44K -1.71M -79.6%
Pura Vida Investments 10.16M +1.51M +17.4%
AMP Ameriprise Financial 3.67M -1.48M -28.7%
MS Morgan Stanley 4.83M +1.11M +29.8%
Susquehanna International 0 -311.33K EXIT
BCS Barclays 16.74K -300.73K -94.7%
Millennium Management 0 -279.54K EXIT
Alliancebernstein 42.1K -233.57K -84.7%

Financial report summary

?

Content analysis

?
Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability
H.S. sophomore Avg
New words: Allan, allergy, ARC, autoimmune, awarded, CDS, classification, covenant, deducted, deducting, deemed, eligible, firm, incurrence, inflation, inflationary, leaseback, lieu, listing, Lux, maximum, MDS, payout, permanent, quality, ratio, recently, recovery, reinforce, repay, Robb, support, upcoming
Removed: adapted, affected, application, applying, appointment, approved, assessment, ASU, August, Authorization, bond, calculating, carried, challenge, clear, combat, combined, commence, Committee, complexity, concordance, conduct, consisted, contract, declared, dedicated, delayed, designated, developed, difficult, distancing, distribution, eased, Emergency, enhance, enhanced, equally, EUA, evolving, expanded, expanding, extent, external, FASB, flow, forfeited, growing, growth, guidance, Health, hedged, Hedging, highly, hiring, impacted, implemented, inducement, initially, institutional, internal, invest, joining, linked, liquidated, lockdown, Manuel, mark, marked, menu, minimal, mitigate, mitigation, moderated, modified, negatively, November, optimized, order, outbreak, phase, postponed, qualitative, quarantine, quoted, rank, realization, receive, recommence, recommended, redeem, relate, relevant, removed, Remuneration, repeatedly, response, restarted, restarting, restriction, retrospective, robust, Rule, salary, scope, segregate, sensitivity, September, shift, social, specificity, spend, spite, spot, standing, stopping, strain, study, submission, submitted, Subtopic, terminated, termination, test, uncertain, unsecured, unsubordinated, USA, validation, vary, varying, verification, vest, widespread, written, yield

Reddit threads